Concepedia
Statistics
Publications
7
Citations
267
H-Index
Active since
2012
Affiliations
Peking University Third Hospital(Current)
Peking University
Peking University People's Hospital
Zhongqiang Yao is an author at Peking University Third Hospital specializing in medicine, cell biology, and immunology.
Top concepts
MedicineCell BiologyImmunologyCell SignalingAutoimmune DiseaseInflammationOsteoporosisRheumatologyOsteoarthritisRheumatoid Arthritis
Publications per year
2012–2024
CRISPR/CAS9-Mediated Genome Editing of miRNA-155 Inhibits Proinflammatory Cytokine Production by RAW264.7 Cells
Weixia Jing, Xuewu Zhang, Wenyan Sun et al. · BioMed Research International · 2015 · 70 citations · Full text
Raw264.7 Cells, Microrna 155, Immunology +21
CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2/STAT3 and p38/MAPK signaling pathway
Changhong Li, Linlin Xu, Jinxia Zhao et al. · Inflammation Research · 2015 · 57 citations
Inflammation, Rheumatology, Cytokine +14
AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis
Changhong Li, Jinxia Zhao, Lin Sun et al. · Biochemical and Biophysical Research Communications · 2013 · 49 citations
Bone Morphogenic Protein, Cell Signaling, Stat3 Activation +8
RANKL downregulates cell surface CXCR6 expression through JAK2/STAT3 signaling pathway during osteoclastogenesis
Changhong Li, Jinxia Zhao, Lin Sun et al. · Biochemical and Biophysical Research Communications · 2012 · 32 citations
Sclerostin, Signal Transduction, Bone Morphogenic Protein +9
Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways
Changhong Li, Zhenzhen Ma, Leilei Jian et al. · International Immunopharmacology · 2020 · 29 citations
Tnf-α Signaling Pathways, Cell Signaling, Iguratimod Inhibits Osteoclastogenesis +8
1–5 of 7